Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange to add 16 more shares to OTC with CCs

8/30/24 MOEX

Nefaz reported for 6 months of 2024 by IFRS

8/30/24 NFAZ

OMZ reported for 6 months of 2024 by IFRS

8/30/24 OMZZP

VTB's profit in July decreased by 42%

8/30/24 VTBR

Globaltrans has no plans to resume dividend payments

8/30/24 GLTR

Globaltrans reported for 6 months of 2024

8/30/24 GLTR

Rosneft increased gas production by 7%

8/30/24 ROSN

Ingrad reported for 6 months of 2024 by IFRS

8/30/24 INGR

Fesco reports for 6 months of 2024 by IFRS

8/30/24 FESH

Rosneft reported for 6 months of 2024 by IFRS

8/30/24 ROSN